1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H2, 2015

Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H2, 2015" provides an overview of Prader-Willi Syndrome (PWS) clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Prader-Willi Syndrome (PWS) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Prader-Willi Syndrome (PWS) 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials 24
Prominent Drugs 25
Latest Clinical Trials News on Prader-Willi Syndrome (PWS) 26
Jun 04, 2015: Rhythm Initiates Two Phase 2 Clinical Trials of Setmelanotide in Rare Genetic Disorders of Obesity Caused by MC4 Pathway Deficiencies 26
May 28, 2015: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome 27
May 08, 2015: Zafgen Presents Positive Safety And Efficacy Data From Phase 2 Trial Of Beloranib In Severe Obesity And Proof Of Concept Trial In Prader-Willi Syndrome At ECO 2015 27
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Novo A/S 29
Clinical Trial Overview of Novo A/S 29
Zafgen Inc. 30
Clinical Trial Overview of Zafgen Inc. 30
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
LG Life Sciences, Ltd. 32
Clinical Trial Overview of LG Life Sciences, Ltd. 32
Ferring International Center S.A. 33
Clinical Trial Overview of Ferring International Center S.A. 33
Essentialis, Inc. 34
Clinical Trial Overview of Essentialis, Inc. 34
Eli Lilly and Company 35
Clinical Trial Overview of Eli Lilly and Company 35
Corporacion Parc Tauli 36
Clinical Trial Overview of Corporacion Parc Tauli 36
Chong Kun Dang Pharmaceutical Corp. 37
Clinical Trial Overview of Chong Kun Dang Pharmaceutical Corp. 37
Alize Pharma SAS 38
Clinical Trial Overview of Alize Pharma SAS 38
Clinical Trial Overview of Top Institutes / Government 39
University Hospital, Toulouse 39
Clinical Trial Overview of University Hospital, Toulouse 39
Aintree University Hospitals NHS Foundation Trust 40
Clinical Trial Overview of Aintree University Hospitals NHS Foundation Trust 40
Dutch Growth Research Foundation 41
Clinical Trial Overview of Dutch Growth Research Foundation 41
Eunice Kennedy Shriver National Institute of Child Health and Human Development 42
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 42
Garvan Institute of Medical Research 43
Clinical Trial Overview of Garvan Institute of Medical Research 43
Radboud University Nijmegen Medical Centre 44
Clinical Trial Overview of Radboud University Nijmegen Medical Centre 44
The Children's Mercy Hospital 45
Clinical Trial Overview of The Children's Mercy Hospital 45
University of Florida 46
Clinical Trial Overview of University of Florida 46
Vancouver General Hospital 47
Clinical Trial Overview of Vancouver General Hospital 47
Weill Cornell Medical College 48
Clinical Trial Overview of Weill Cornell Medical College 48
Five Key Clinical Profiles 49
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 73

List of Tables
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Prader-Willi Syndrome (PWS) Therapeutics, Global, Terminated Clinical Trials, 2015* 20
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 29
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zafgen Inc., 2015* 30
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 31
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2015* 32
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 33
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Essentialis, Inc., 2015* 34
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 35
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Corporacion Parc Tauli, 2015* 36
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chong Kun Dang Pharmaceutical Corp., 2015* 37
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alize Pharma SAS, 2015* 38
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2015* 39
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aintree University Hospitals NHS Foundation Trust, 2015* 40
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dutch Growth Research Foundation, 2015* 41
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 42
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Garvan Institute of Medical Research, 2015* 43
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2015* 44
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2015* 45
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 46
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vancouver General Hospital, 2015* 47
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 48

List of Figures
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.